Paclitaxel composition for injection and preparation method thereof

A paclitaxel and composition technology, applied in the directions of drug combination, drug delivery, pharmaceutical formulation, etc., can solve the problems such as the lack of detailed description of the preparation process, the increase in the content of related substances, the increase in the degradation products of the main drug, and the reduction of adverse reactions. Occurrence rate, the effect of reducing the content of related substances and improving the stability

Inactive Publication Date: 2012-07-11
JIANGSU AOSAIKANG PHARMA CO LTD
View PDF6 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] Experimental studies have found that paclitaxel will be degraded to varying degrees under conditions of light, alkali, acid, and high temperature, especially in high alkalinity and high heat, which will increase the content of related substances. Therefore, after the injection preparation and filling are completed The advanced terminal sterilization process (generally adopting 115°C, 30 minutes) may affect the product quality, increase the degradation products (related substances) of the main drug, and bring the risk of clinical use
[0012] A paclitaxel injectable composition is mentioned in CN1248680C. In this technology, the quality evaluation and stability expression of the paclitaxel injectable composition are mainly described from the aspects of paclitaxel content, particle size after dilution, and product toxicity. There is no detailed description of degradation products (related substances), clinical compatibility stability, and the preparation process of the injectable composition, and the clinical allergic reaction of the paclitaxel injectable composition, which is the most important adverse reaction, has an advantage in this composition not reflected

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Paclitaxel composition for injection and preparation method thereof
  • Paclitaxel composition for injection and preparation method thereof
  • Paclitaxel composition for injection and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Sterilization of polyoxyethylene-35-castor oil by conventional methods

[0034] prescription

[0035] Paclitaxel 30g

[0036] Polyoxyl-35-Castor Oil 2650g

[0037] Citric acid 10g

[0038] Ethanol up to 5000ml

[0039]

[0040] A total of 1000 bottles were made

[0041] Polyoxyethylene-35-castor oil, autoclaved at 120°C for 20 minutes, cooled to room temperature for later use.

[0042] Take polyoxyethylene-35-castor oil and put it in a stainless steel bucket, add paclitaxel into it, stir for 30 minutes to mix the raw and auxiliary materials evenly, add 80% ethanol, continue stirring for 15 minutes, then add citric acid, and continue stirring for 5 minutes , add ethanol to the full amount, filter through two-stage 0.22um polytetrafluoroethylene capsule filters, measure the solution content and pH value, check the clarity of the liquid medicine, and fill the liquid medicine in a glass ampoule after passing the test, and seal it , l...

Embodiment 2

[0044] Sterilization of polyoxyethylene-35-castor oil by conventional methods

[0045] prescription

[0046] Paclitaxel 30g

[0047] Polyoxyl-35-Castor Oil 2650g

[0048] Citric acid 10g

[0049] Ethanol up to 5000ml

[0050]

[0051] A total of 1000 bottles were made

[0052] Polyoxyethylene-35-castor oil, autoclave at 115°C for 30 minutes, cool to room temperature for later use.

[0053]Take polyoxyethylene-35-castor oil and put it in a stainless steel bucket, add paclitaxel into it, stir for 30 minutes to mix the raw and auxiliary materials evenly, add 80% ethanol, continue stirring for 15 minutes, then add citric acid, and continue stirring for 5 minutes , add ethanol to the full amount, filter through two-stage 0.22um polytetrafluoroethylene capsule filters, measure the solution content and pH value, check the clarity of the liquid medicine, and fill the liquid medicine in a glass ampoule after passing the test, and seal it , light inspection,...

Embodiment 3

[0055] prescription

[0056] Paclitaxel 30g

[0057] Polyoxyl-35-Castor Oil 2600g

[0058] Citric acid 10g

[0059] Ethanol up to 5000ml

[0060]

[0061] A total of 1000 bottles were made

[0062] Polyoxyethylene-35-castor oil, autoclave at 105°C for 30 minutes, cool to 40°C, repeat the above process twice, cool to room temperature for later use.

[0063] Take polyoxyethylene-35-castor oil and put it in a stainless steel bucket, add paclitaxel into it, stir for 30 minutes to mix the raw and auxiliary materials evenly, add 80% ethanol, continue stirring for 15 minutes, then add citric acid, and continue stirring for 5 minutes , add ethanol to the full amount, filter through two-stage 0.22um polytetrafluoroethylene capsule filters, measure the solution content and pH value, check the clarity of the liquid medicine, and fill the liquid medicine in a glass ampoule after passing the test, and seal it , light inspection, forming paclitaxel composition fo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a paclitaxel composition for injection. The composition comprises the following components in percentage by weight: 0.200-1.087% of paclitaxel, 95.000-99.200% of polyoxyethylenated castor oil and ethanol as well as 0.200-1.500% of organic acid. The paclitaxel composition for injection, provided by the invention, can be directly administrated after being diluted by an infusion solution. By using the paclitaxel composition for injection, provided by the invention, the damage caused by terminal sterilization of the product to the main component is avoided because a sterile production process is adopted in the preparation process; meanwhile, the sterile level of the product is more preferably guaranteed because an polyoxyethylenated castor oil sterilizing process is additionally increased in the process. Compared with the prior art, the paclitaxel composition for injection, provided by the invention, has the advantages of reducing the content of the preparation related substances, improving the product stability, reducing the occurring rate of the adverse reaction and improving the safety in clinical use.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to the field of medicine preparation of compositions. Background technique [0002] The chemical name of paclitaxel is: (2S, 5R, 7S, 10R, 13S)-10,20-bis(acetoxy)-2-benzoyloxy-1,7-dihydroxy-9-oxo-5, 20-Epoxytaxane-11-en-13-yl(3S)-3-benzamido-3-phenyl-D-lactate. [0003] Its structural formula is: [0004] [0005] Molecular formula: C 47 h 51 NO 14 [0006] Molecular weight: 853.92 [0007] Paclitaxel is a new type of anti-microtubule drug, which can act on the microtubule / tubulin system of cells, promote the assembly of tubulin into microtubules, but inhibit the depolymerization of microtubules, resulting in abnormal arrangement of microtubule bundles and the formation of stars. The spindle loses its normal function, leading to the death of microcells. The drug also induces the formation of nonfunctional microtubules in the absence of guanosine triphosphate (GTP) a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/337A61K47/44A61P35/00
Inventor 蔡继兰吴宏坚赵卉
Owner JIANGSU AOSAIKANG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap